Please try another search
JW Shinyak Corporation engages in the production and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells. JW Shinyak Corporation was founded in 1981 and is headquartered in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Pil-Gyu Kim | - | 2023 | Independent Outside Director |
Jeong-Woon Wang | - | - | Executive Director |
Yong-Kwan Kim | - | 2023 | CEO & Director |
Myung-Chul Lee | - | - | Independent Outside Director |
Yeon-Seok Son | - | - | Independent Outside Director |
Kyung-Kook Tak | - | 2023 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review